Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Admed s.r.o.

Czechia Tr. Csl. Legii 2118/6, 370 06 Ceske Budejovice, Czechia

  • 1 trial recruiting
  • Erythema migrans · Antibiotic therapy
  • Adult patients

About Specializations

Admed s.r.o. in Ceske Budejovice, Czechia specialises in clinical trials of conditions such as Erythema migrans, Antibiotic therapy, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The research at Admed s.r.o. includes a study evaluating the impact of a probiotic on gut microbiota in patients receiving antibiotic therapy for early skin Lyme disease.

  • Probiotic modulation of microbiome composition
  • Prevention of antibiotic‑associated dysbiosis
  • Management strategies for erythema migrans

Findings aim to improve supportive care for infections while preserving digestive health.

Virus Diseases

A trial at the clinic assesses a combined Respiratory Syncytial Virus and Human Metapneumovirus protein vaccine candidate intended to prevent lower respiratory tract disease in adults over 60.

  • Efficacy of RSV prevention in seniors
  • Protection against HMPV‑related illness
  • Safety profile of the vaccine in older populations

The study supports development of broader viral respiratory vaccines for the aging community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Tr. Csl. Legii 2118/6370 06 Ceske BudejoviceCzechia
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2

More sites in Ceske BudejoviceCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Erythema migrans+1

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Biocodex

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Sanofi Pasteur Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.